Wilson Sonsini Goodrich & Rosati advised Absci on the transaction. Absci Corporation (Nasdaq: ABSI) announced a collaboration with AstraZeneca, a global biopharmaceutical company, to deliver an AI-designed...
Absci’s Collaboration with Astrazeneca
L Catterton’s $680 Million Acquisition of Thorne HealthTech
Kirkland & Ellis LLP is representing L Catterton, and Wilson Sonsini Goodrich & Rosati is representing Thorne HealthTech, Inc. in the transaction. Thorne HealthTech, Inc. (“Thorne”)...
Laekna’s HK$791 Million Initial Public Offering
Davis Polk, Jingtian & Gongcheng and Harney Westwood advised Laekna, while Cooley and Commerce & Finance Law Offices advised the sole sponsor and the underwriters. Laekna,...
ZJLD Group’s HK$5.3 Billion Initial Public Offering
Davis Polk advised ZJLD Group on the offering, while Cleary Gottlieb advised the joint sponsors, and the overall coordinators, joint global coordinators, joint bookrunners, and joint...
Bilibili’s Equity Offering and Notes Exchange
Skadden advised Bilibili Inc. and Davis Polk advised the underwriter involved. Bilibili announced an equity underwriting and notes exchange agreement with Goldman Sachs (Asia) L.L.C. to issue...
Kingsoft Cloud’s Hong Kong Dual Primary Listing
Maples and Calder, Davis Polk and Fangda acted for Kingsoft Cloud Holdings Limited on the dual listing. Simpson Thacher represented the joint sponsors. Kingsoft Cloud Holdings...
Inspirato’s Merger with Thayer Ventures Acquisition Corp.
Wilson Sonsini Goodrich & Rosati advised Inspirato on the deal. Simpson Thacher advised UBS Securities LLC, Evercore Group L.L.C., and Stifel, Nicolaus & Company on the...
NuVasive’s Acquisition of Simplify Medical
Wilson Sonsini Goodrich & Rosati advised Simplify Medical on the deal. NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally...